Thursday, April 13, 2017

Can you hear us now?

Weather or not our story made a difference in the decision with the current changes to the USPSTF.

I am excited to hear The USPSTF recommends that clinicians inform men ages 55 to 69 years about the potential benefits and harms of prostate-specific antigen (PSA)–based screening for prostate cancer.

No comments: